Egypt: Tomorrow, a line will open to increase the production of poultry vaccines to one billion two hundred million doses annually

Published 2022년 3월 14일

Tridge summary

The Institute of Serum and Veterinary Vaccines in Abbasiya, Egypt, is set to inaugurate a new poultry vaccine production line, set to produce over 1.2 billion doses of veterinary vaccines annually. The institute, which was established in 1903 and has a long history of producing vaccines against various animal and poultry diseases, is affiliated with the Ministry of Agriculture. It has 14 departments, including research and production of domestic pet vaccines, foot-and-mouth disease research, genetic engineering research, and production of the rinderpest vaccine. The institute has a capacity to produce 6 million doses of the foot-and-mouth disease vaccine annually and has successfully used the Roman strain sheep pox vaccine to immunize livestock against streptococcal skin disease.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The Minister of Agriculture and Land Reclamation will inaugurate tomorrow, Tuesday, the latest line for the production of poultry vaccines at the Institute of Serum and Veterinary Vaccines in Abbasiya, and it will contribute to raising and increasing Egypt’s production of more than one billion and two hundred million doses annually. And the veterinary vaccines in Abbasiya was established in 1903, on the Red Mountain hills, and it was called the veterinary laboratory for serum to produce the vaccine, and it produced serum for plague patients, which leaked into Egypt at that time and caused heavy losses, and it was affiliated with the Ministry of Health. In 1914 his affiliation was transferred to the Ministry of Agriculture as one of the research institutes affiliated to the Agricultural Research Center, where it is considered a fortress against diseases that affect livestock and poultry. In 1928 the septicemia vaccine and the laxative vaccine were prepared for the disease of ...
Source: Akhbarelyom

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.